市場調査レポート

商品コード

1619080

幹細胞アッセイ市場規模、シェア、成長分析、製品タイプ別、アッセイタイプ別、用途別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

Stem Cell Assay Market Size, Share, Growth Analysis, By Product Type (Instruments, Flow Cytometers), By Assay Type (Cell Viability & Toxicity Assays, Cell Identification Assays), By Application, By End-User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 767,811円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 898,194円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,028,577円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.87円

全表示
概要
目次

概要

サンプル依頼リストに入れる

幹細胞アッセイの世界市場規模は、2022年に19億米ドルと評価され、2023年の22億4,000万米ドルから2031年には82億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは17.7%で成長する見通しです。

幹細胞アッセイ市場は、入手困難な細胞種の安定した入手可能性と生理学的関連モデルの開発によって大きな成長を遂げています。最近の医療インフラの進歩や技術革新は、治療プロトコルを変革し、新規治療法やジェネリック医薬品の発見を促進しています。特にハイスループットスクリーニング環境では、細胞生存率、細胞毒性、老化などの重要なパラメーターを評価するために、細胞ベースのアッセイがますます採用されるようになっています。さらに、幹細胞アッセイへの投資の高まりと研究イニシアチブの強化が、より安全な治療法の出現を後押ししています。医学研究や創薬における幹細胞アッセイに対する需要の高まりは、製薬セクターの拡大と相まって、このダイナミックな市場を前進させ続けています。

市場概要
細胞生存率および毒性アッセイ
- Mttアッセイ
- トリパンブルー除外試験
細胞識別試験
- 免疫細胞化学
- フローサイトメトリー
細胞増殖試験
- Brduアッセイ
- EdUアッセイ
細胞分化試験
- アルカリホスファターゼ試験
- 免疫蛍光アッセイ
その他
- アポトーシス試験
- 移動試験

幹細胞アッセイ市場規模：用途別およびCAGR（2024～2031年）

市場概要
再生医療と治療法の開発
- 神経学
- 腫瘍学
- 心臓血管
医薬品の発見と開発
- 毒性試験
- 有効性試験
臨床調査
- 疾患モデル
- 幹細胞の特性評価

幹細胞アッセイ市場規模：エンドユーザー別およびCAGR（2024～2031年）

市場概要
製薬・バイオテクノロジー企業
- 医薬品開発
- 品質管理
学術調査機関
- 基礎調査
- トランスレーショナル調査
契約調査機関（Cros）
- 前臨床研究
- 臨床試験

幹細胞アッセイ市場規模およびCAGR（2024～2031年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Thermo Fisher Scientific Inc.（USA）
Merck KGaA（Germany）
Danaher Corporation（USA）
Becton, Dickinson and Company（USA）
Bio-Rad Laboratories, Inc.（USA）
Promega Corporation（USA）
Bio-Techne Corporation（USA）
FUJIFILM Holdings Corporation（Japan）
Charles River Laboratories（USA）
HemoGenix, Inc.（USA）
Lonza Group（Switzerland）
Takara Bio Inc.（Japan）
Creative Bioarray（USA）
AAT Bioquest, Inc.（USA）
BPS Bioscience, Inc.（USA）
Enzo Biochem, Inc.（USA）
PromoCell GmbH（Germany）
Biotium, Inc.（USA）
Geno Technology, Inc.（USA）

結論と推奨事項

Product Code: SQMIG35H2123

Global Stem Cell Assay Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.24 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 17.7% during the forecast period (2024-2031).

The stem cell assay market is experiencing significant growth driven by the consistent availability of hard-to-source cell types and the development of physiologically relevant models. Recent advancements in medical infrastructure and technology innovations have transformed treatment protocols and facilitated the discovery of novel therapies and generic drugs. Cell-based assays are increasingly employed to evaluate key parameters such as cell viability, cytotoxicity, and senescence, particularly within high-throughput screening environments. Furthermore, heightened investment and intensified research initiatives in stem cell assays have fostered the emergence of safer treatment options. The rising demand for stem cell-based assays in medical research and drug discovery, coupled with the expansion of the pharmaceutical sector, continues to propel this dynamic market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Assay Market Segmental Analysis

Global Stem Cell Assay Market is segmented by product type, assay type, application, end-user and region. Based on product type, the market is segmented into instruments and consumables. Based on assay type, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell differentiation assays and others. Based on application, the market is segmented into regenerative medicine & therapy development, drug discovery & development and clinical research. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Assay Market

The global stem cell assay market is fundamentally influenced by a rising health consciousness among the population and ongoing population growth. While the COVID-19 pandemic posed significant challenges for various sectors, the stem cell assay market demonstrated resilience, with key players maintaining their product offerings despite the downturn. The continuous advancements in stem cell assays not only address the complexities of global demand but also enhance the quality of care provided to patients. As health awareness escalates, the demand for innovative stem cell assays is likely to grow, positioning the market for sustained development in the future.

Restraints in the Global Stem Cell Assay Market

The Global Stem Cell Assay market faces several restraints, one of the most significant being the high cost of raw materials. This economic challenge affects various industrial sectors, hindering their ability to maintain sustainable production operations. The elevated expenses associated with sourcing essential materials can lead to increased pricing for finished products, ultimately impacting market growth and accessibility. Companies in the stem cell research and therapeutic fields may struggle to balance the need for quality inputs with budget constraints, potentially limiting innovation and the advancement of stem cell technologies. Therefore, addressing this financial barrier is crucial for the market's overall development.

Market Trends of the Global Stem Cell Assay Market

The Global Stem Cell Assay market is witnessing a notable upward trend, driven by the rising emphasis on personalized medicine and regenerative therapies. This greater focus has catalyzed the demand for stem cell assays, essential for streamlining drug discovery and development processes. Furthermore, significant technological advancements and the integration of automation have markedly improved the efficiency and accuracy of these assays, resulting in superior research outcomes and cost-effectiveness. As pharmaceutical companies and research institutions increasingly prioritize these innovative approaches, the stem cell assay market is poised for substantial growth, reflecting broader shifts toward precision and tailored healthcare solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies

Global Stem Cell Assay Market Size by Product Type & CAGR (2024-2031)

Market Overview
Instruments
- Flow Cytometers
- Microelectrode Arrays
- Cell Imaging Systems
Consumables
- Reagents & Kits
- Microplates
- Assay Kits

Global Stem Cell Assay Market Size by Assay Type & CAGR (2024-2031)

Market Overview
Cell Viability & Toxicity Assays
- Mtt Assay
- Trypan Blue Exclusion Assay
Cell Identification Assays
- Immunocytochemistry
- Flow Cytometry
Cell Proliferation Assays
- Brdu Assay
- Edu Assay
Cell Differentiation Assays
- Alkaline Phosphatase Assay
- Immunofluorescence Assay
Others
- Apoptosis Assays
- Migration Assays

Global Stem Cell Assay Market Size by Application & CAGR (2024-2031)

Market Overview
Regenerative Medicine & Therapy Development
- Neurology
- Oncology
- Cardiovascular
Drug Discovery & Development
- Toxicology Testing
- Efficacy Testing
Clinical Research
- Disease Modeling
- Stem Cell Characterization

Global Stem Cell Assay Market Size by End-User & CAGR (2024-2031)

Market Overview
Pharmaceutical & Biotechnology Companies
- Drug Development
- Quality Control
Academic & Research Institutes
- Basic Research
- Translational Research
Contract Research Organizations (Cros)
- Preclinical Studies
- Clinical Trials

Global Stem Cell Assay Market Size & CAGR (2024-2031)

North America (Product Type, Assay Type, Application, End-User)
- USA
- Canada
Europe (Product Type, Assay Type, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Assay Type, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Assay Type, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Assay Type, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HemoGenix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AAT Bioquest, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BPS Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotium, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geno Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

幹細胞アッセイ市場規模、シェア、成長分析、製品タイプ別、アッセイタイプ別、用途別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

Stem Cell Assay Market Size, Share, Growth Analysis, By Product Type (Instruments, Flow Cytometers), By Assay Type (Cell Viability & Toxicity Assays, Cell Identification Assays), By Application, By End-User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

幹細胞アッセイ市場規模：製品タイプ別およびCAGR（2024～2031年）

幹細胞アッセイ市場規模：アッセイタイプ別およびCAGR（2024～2031年）